Error loading player: No playable sources found

4515

Dietary and Microbial Derived Bioactive Compounds: Impact on Gastrointestinal Mucosal Health

Date
May 20, 2024

SOCIETY: AGA Natural products obtained from diet or microbial derived metabolites are increasingly gaining attention for their potential therapeutic potential in gastro-intestinal disorders. These metabolites range from aryl hydrocarbon receptor ligands present in cruciferous vegetables, flavonoids, tryptophan derived metabolites, short chain fatty acids from microbial fermentation of undigestible fibers or microbially modified metabolites such as secondary bile acids. An increased understanding of how these metabolites affect the host intestinal mucosal processes is essential to harness their therapeutic potential fully. This symposium aims to bring together key advances in the field by highlighting complex interactions of microbiota and production of metabolites with mechanisms relevant to gut mucosal health and diseases.

Moderators

Speaker Image for Ravinder Gill
Univ of Illinois at Chicago
Speaker Image for Sean Colgan
University of Colorado

Related Products

Thumbnail for Gut Microbiome — Ally or Foe for Immune Checkpoint Inhibitors
Gut Microbiome — Ally or Foe for Immune Checkpoint Inhibitors
SOCIETY: AGA This session will explore the complex dynamics between the gut microbiome and immune checkpoint inhibitors, addressing whether specific microbes/metabolites enhance therapeutic outcomes acting as allies or present challenges as potential foes, impacting treatment efficacy and associate…
Thumbnail for AGA Diet-Driven Gut Microbiome Dynamics, Metabolism and Extinction
AGA Diet-Driven Gut Microbiome Dynamics, Metabolism and Extinction
This session showcases the pioneering work done by the MMT section mentor awardee Dr. Justin Sonnenburg and his mentees who are leading independent programs focused on the intersection of diet-microbe-host physiology…
Thumbnail for Tiny Ecosystems, Big Impact: Unlocking the Secrets of the Early Life Microbiome
Tiny Ecosystems, Big Impact: Unlocking the Secrets of the Early Life Microbiome
SOCIETY: AGA This session is focused on the early life microbiome and its importance for immune maturation that affects both childhood diseases as well as future development of allergic and autoimmune diseases…
Thumbnail for Microbiome Therapeutics: Charting the Path to Clinical Success
Microbiome Therapeutics: Charting the Path to Clinical Success
SOCIETY: AGA The session will highlight the current state of microbiome therapeutics, the challenges with developing and testing them in humans and the outlook for future of microbiome therapies beyond FMT…